What a great news. Really hope this will be a sign of hope towards breakthrough in treating breast cancer.
Exact Sciences receives regulatory approval for the Oncotype DX Breast Recurrence Score® Program in Japan
MADISON, Wis., Aug. 16, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced tha
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
点赞
举报
登录后可参与评论
![empty](https://c1.itigergrowtha.com/community/assets/media/empty-default.06ba11e0.png)
暂无评论